Prognostic Value of the Brixia Radiological Score in COVID-19 Patients: A Retrospective Study from Romania
- PMID: 40423360
- PMCID: PMC12115630
- DOI: 10.3390/tropicalmed10050130
Prognostic Value of the Brixia Radiological Score in COVID-19 Patients: A Retrospective Study from Romania
Abstract
The novel coronavirus pandemic, SARS-CoV-2, has a variable clinical spectrum, ranging from asymptomatic to critical forms. High mortality and morbidity rates have been associated with risk factors such as comorbidities, age, sex, and virulence factors specific to viral variants. Material and Methods: We retrospectively evaluated imaging characteristics using the Brixia radiological score in relation to favorable or unfavorable outcomes in adult patients. We included COVID-19 cases, admitted between 2020 and 2022, in a specialized pulmonology hospital with no intensive care unit. We analyzed 380 virologically confirmed COVID-19 cases, with a mean age of 52.8 ± 13.02 years. The mean Brixia radiological score at admission was 5.13 ± 3.56, reflecting predominantly mild-to-moderate pulmonary involvement. Multivariate analysis highlighted the utility of this score as a predictive marker for COVID-19 prognosis, with values >5 correlating with other severity biomarkers, NEWS-2 scores, and a lack of vaccination and hospitalization delay of more than 6 days from symptom onset. Summarizing, the Brixia score is itself an effective tool for screening COVID-19 cases at risk of death for early recognition of clinical deterioration and for decisions regarding appropriate care settings. Promoting vaccination can reduce the severity of radiological lesions, thereby decreasing the risk of death. Technologies based on artificial intelligence could optimize diagnosis and management decisions.
Keywords: Brixia score; COVID-19; emerging infectious disease; predictor death.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Sočan M., Mrzel M., Prosenc K., Korva M., Avšič-Županc T., Poljak M., Lunar M.M., Zupanič T. Comparing COVID-19 severity in patients hospitalized for community-associated Delta, BA.1 and BA.4/5 variant infection. Front. Public Health. 2024;12:1294261. doi: 10.3389/fpubh.2024.1294261. - DOI - PMC - PubMed
-
- Pleșea-Condratovici C., Gatej E.R., Rizeanu S., Pleșea-Condratovici A. Anxiety in home-quarantined patients with COVID-19. Brain. 2022;13:347–360. doi: 10.18662/brain/13.1/288. - DOI
LinkOut - more resources
Full Text Sources
Miscellaneous
